Recombinant Human CSTL1 Protein (HEK293)，hFc

CSTL1, or the Cystatin-like protein 1, is a member of the cystatin superfamily, which plays a critical role in regulating proteolytic enzymes and maintaining protein homeostasis in biological systems. Research on CSTL1 has gained interest due to its potential involvement in various physiological processes and disease states, particularly in cancer and inflammatory responses. Numerous studies have indicated that CSTL1 may act as a tumor suppressor, inhibiting cell proliferation and metastasis, making it a target of interest in cancer therapy. Its expression levels have been correlated with patient outcomes in several malignancies, prompting investigations into the mechanisms by which CSTL1 modulates tumor biology. Additionally, CSTL1’s interaction with other cellular pathways positions it as a key player in both innate immune responses and tissue remodeling. Furthermore, the recombinant production of CSTL1 protein facilitates detailed functional assays and structural studies, paving the way for the development of novel therapeutic strategies. Understanding the biological functions and molecular mechanisms of CSTL1 can provide valuable insights into its role in health and disease, thereby advancing potential clinical applications in diagnostics and targeted therapies. Consequently, the ongoing research into CSTL1 not only elucidates its fundamental biological roles but also holds promise for innovative approaches to managing various diseases.